TherapeuticsMD Inc

NASDAQ:TXMD   12:59:43 PM EDT
1.36
+0.02 (+1.49%)
Earnings Announcements

Therapeuticsmd Announces Third Quarter 2020 Financial Results

Published: 11/09/2020 12:01 GMT
TherapeuticsMD Inc (TXMD) - Therapeuticsmd® Announces Third Quarter 2020 Financial Results.
Q3 Loss per Share $0.12.
Q3 Revenue Rose 80 Percent to $19.3 Million.
Q3 Revenue Estimate $15.3 Million -- Refinitiv Ibes Data (analyst estimates).
Q3 Earnings per Share Estimate $-0.14 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $22.72 Million
Adjusted EPS is expected to be -$0.10

Next Quarter Revenue Guidance is expected to be $27.2 Million
Next Quarter EPS Guidance is expected to be -$0.09

More details on our Analysts Page.